Chinese Orthopedic Biomaterials Market
London (PRWEB) September 25, 2013 -- The Chinese orthopedic biomaterials market is expected to approach $522.3 million by 2019.
The bone graft substitute segment is expected to constitute the majority of the Chinese orthopedic biomaterials market.
The Chinese orthopedic biomaterials market comprises bone graft substitutes which is segmented into allografts, demineralized bone matrices (DBM) and synthetics, and hyaluronic acid (HA) viscosupplementation. The market has seen increased interest in domestic competitors and some domestic competitors are in the process of clinical trials for synthetic, DBM, and bone morphogenetic protein (BMP) products. Further growth in the overall market will be fuelled by the Chinese government improving healthcare coverage across the country, leading to an increase in the number of Chinese people with more disposable income. The previous drivers are magnified by the increasing population of elderly, and the increased acceptance of surgery as a solution.
Scope:
This report pertains to a forecast period of 10 years (2009 – 2019) for China.
Report Contents:
Competitor Analysis
Identified Strategic Opportunities
Market Overview by Segment & Country
Trend Analysis by Segment & Country
Market Drivers & Limiters
Mergers & Acquisitions
Customer Feedback and Market Monitoring
Main Markets Included:
Bone Graft Substitute
Hyaluronic Acid Viscosupplementation
Sub-Segments Included:
Synthetic Allograft
Demineralized Bone Matrix
Cervical Spine
Thoracolumbar Spine
Trauma & Reconstruction
Craniomaxillofacial
Single-injection products
Three-injection cycle products
Five-injection cycle products
Companies Included:
Wright Medical
Bloomage Freda Biopharm
Shanghai Haohai Biological
Kunming Baker Norton
Shanghai Baijiayi
Xin Kang Cheng
Shanxi Aurui
Biolu
Hubei Lianjie
Shanghai Anjiu
Biocomposites
DePuy Synthes NovaBone
Rebone
Others Include:
Award Trade Corporation (Kunming), Beijing Fito Medical, Beijing St. Jane Medical, Liweize Medical Devices, Shanghai Medcare, Shenzhen SMARL, and various domestic companies.
Reasons To Buy:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
TABLE OF CONTENTS I
LIST OF FIGURES IV
LIST OF CHARTS VI
EXECUTIVE SUMMARY 1
1.1 CHINESE MARKET FOR ORTHOPEDIC BIOMATERIALS 1
1.2 GROWTH TRENDS BY SEGMENT 1
1.3 PROCEDURES 1
1.4 BONE GRAFT SUBSTITUTE MARKET 1
1.5 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 1
1.6 COMPETITIVE ANALYSIS 1
RESEARCH METHODOLOGY 2
2.1 RESEARCH SCOPE 2
2.2 IDATA’S 9-STEP METHODOLOGY 2
Step 1: Project Initiation & Team Selection 3
Step 2: Prepare Data Systems and Perform Secondary Research 5
Step 3: Preparation for Interviews & Questionnaire Design 6
Step 4: Performing Primary Research 7
Step 5: Research Analysis: Establishing Baseline Estimates 9
Step 6: Market Forecast and Analysis 10
Step 7: Identify Strategic Opportunities 12
Step 8: Final Review and Market Release 13
Step 9: Customer Feedback and Market Monitoring 13
CHINESE ORTHOPEDIC BIOMATERIALS MARKET 14
3.1 INTRODUCTION 14
3.1.1 Growth Factors 15
3.1.2 Bone Graft Substitutes 15
3.1.3 Hyaluronic Acid Viscosupplementation 15
3.2 CURRENCY EXCHANGE RATE 16
3.3 PROCEDURES 17
3.3.1 Total Orthopedic Bone Graft Substitute Procedures by Indication 17
3.3.2 Total Orthopedic Bone Graft Substitute Procedures by Segment 21
3.3.3 Bone Graft Substitute Procedures 25
3.3.4 Hyaluronic Acid Viscosupplementation Procedures 26
3.4MARKET OVERVIEW 27
3.5 TREND ANALYSIS 32
3.6MARKET DRIVERS AND LIMITERS 33
3.6.1 Market Drivers 33
3.6.2 Market Limiters 33
3.7 COMPETITIVE ANALYSIS 35
3.7.1 Leading Competitors 35
3.7.2 Market Concentration 36
3.8MERGERS AND ACQUISITIONS 38
BONE GRAFT SUBSTITUTE MARKET 39
4.1 INTRODUCTION 39
4.1.1.1 Autograft 40
4.1.1.2 Non-Proprietary Allograft 40
4.1.1.3 Demineralized Bone Matrix 40
4.1.1.4 Synthetic 41
4.1.2 Volumes Represented per Procedure 42
4.2MARKET OVERVIEW 43
4.3MARKET ANALYSIS & FORECAST 45
4.3.1 Allograft Market 49
4.3.1.1 Total Allograft Market 49
4.3.2 Synthetic Market 52
4.3.2.1 Total Synthetic Market 52
4.3.3 Demineralized Bone Matrix Market 54
4.3.3.1 Total DBM Market 54
4.3.4 Market by Indication 56
4.3.5 Cervical Market 59
4.3.6 Thoracolumbar Market 62
4.3.7 Trauma & Reconstruction Market 65
4.3.8 Craniomaxillofacial Market 68
4.3.8.1 Craniomaxillofacial Market 68
4.4 DRIVERS AND LIMITERS 71
4.4.1 Market Drivers 71
4.4.2 Market Limiters 71
4.5 COMPETITIVE ANALYSIS 73
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 75
5.1 INTRODUCTION 75
5.1.1.1 Single-Injection Products 76
5.1.1.2 Three-Injection Cycle Products 76
5.1.1.3 Five-Injection Cycle Products 76
5.2MARKET OVERVIEW 77
5.3MARKET ANALYSIS & FORECAST 79
5.3.1 Single Injection Market 83
5.3.2 Three Injection Cycle Market 86
5.3.3 Five Injection Cycle Market 88
5.4 DRIVERS AND LIMITERS 90
5.4.1 Market Drivers 90
5.4.2 Market Limiters 90
5.5 COMPETITIVE ANALYSIS 92
APPENDIX: (OPTIONAL) 94
ABBREVIATIONS 95
Read the full report:
Chinese Orthopedic Biomaterials Market
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com
Sarah Smith, Research Advisor at Reportbuyer.com, +44 208 816 85 48, [email protected]
Share this article